Tag: Study
-
Companies Of The UN Global Compact Across Europe Make Tangible Contributions To The Sustainable Development Goals But Still Lack Operational Actions To Advance Environmental Goals
Release of the first comprehensive analysis of the private sector’s contribution to the 2030 agendaNEW YORK, Sept. 25, 2026 /PRNewswire/ — On the occasion of the United Nations General Assembly, UN Global Compact Networks Bulgaria, Finland, France, Germany, Italy, the United Kingdom and Türkiye are…
-
Hylenr Completes Phase 1 LCF Reactor Validation at Texas A&M University
Phase 1 testing identified key thermal, noble-gas and material signatures in the Lattice Confinement Fusion (LCF) reactor, with Hylenr now advancing to Phase 2 studies focused on reproducibility, quantitative measurement and commercialization.HYDERABAD, India, Sept. 22, 2026 /PRNewswire/ — Hyderaba…
-
Merry Life Biomedical Advances Global Phase 2 Trial of TML-6, Exploring Cellular Protein Clearance in Early Alzheimer's Disease
Global study brings together nine Taiwan medical centers, seven Swedish sites, and four U.S. centers to evaluate an oral therapy focused on autolysosomal biologyTAIPEI, Sept. 22, 2026 /PRNewswire/ — Merry Life Biomedical today announced the advancement of TML-6, a Taiwan-developed investigational o…
-
New IBM CHRO Study: AI Puts Critical Thinking at the Center of Workforce Priorities
60% of employees worry AI is eroding their skills, with critical thinking cited most often as decliningNearly half of organizations do not involve the CHRO when AI strategy is being definedARMONK, N.Y., Sept. 21, 2026 /PRNewswire/ — A new global study from the IBM (NYSE: IBM) Institute for Business…
-
New Peer-Reviewed Study Confirms Innovative Technology Shatters ESR's Four-Hour Deadline
ALCOR Scientific’s iSED® analyzers reshape lab logistics and improve patient care for one of medicine’s most widely used testsSeven times longer stability, independently validated. ESR samples on ALCOR Scientific’s iSED analyzer remained accurate for up to 28 hours at room temperature and 48 hours r…
-
LANDMARK GLOBAL STUDY REVEALS CRITICAL INEQUITIES IN ACCESS TO DERMATOLOGICAL CARE
First comprehensive global assessment by the International League of Dermatological Societies (ILDS) and L’Oréal Dermatological Beauty spans 158 countries and 97% of the world’s population.Summary: The Global Access to Skin Health Observatory Study, published in JAMA Dermatology, examines the distri…
-
Businesses Achieved 322% ROI with Avalara, According to New Total Economic Impact Study
New study finds a composite Avalara customer realized $1.2 million in benefits and $881,000 in net present value over three years, with payback in under six monthsPUNE, India, Sept. 9, 2026 /PRNewswire/ — Avalara, Inc., the agentic AI leader in global tax and compliance, today announced the results…
-
Chandigarh University's 50 Students to Study in Top Universities of UK, Canada, Germany, France
Students to Gain Global Academic Exposure in Emerging Domains including Deep-Tech, Aerospace, AI & Data Science at Prestigious UniversitiesCHANDIGARH, India, Sept. 8, 2026 /PRNewswire/ — Marking another significant stride in its efforts to provide students with global academic exposure, Chandig…
-
NovaGo Therapeutics Closes USD 30 Million Series B Financing to Advance Proof-of-Concept Study in Acute Spinal Cord Injury
Round led by Neurimmune and Pureos, with participation from existing and new investors; complemented by non-dilutive funding from the Swiss Paraplegic Foundation and Wings for Life – Spinal Cord Research Foundation.SCHLIEREN, Switzerland, Sept. 2, 2026 /PRNewswire/ — NovaGo Therapeutics AG, a clini…
-
Laminar Pharma Announces "Last Patient, Last Visit" in LAM561 Phase 2b/3 Trial for Newly Diagnosed Glioblastoma Patients
PALMA DE MALLORCA, Spain, July 24, 2026 /PRNewswire/ — Laminar Pharma, a leader in the development of innovative therapies based on a novel membrane lipid therapy approach, today announced that the last patient has completed their last visit (LPLV) in the company’s Phase 2b/3 clinical trial of its …
Latest News
About the Author
Your reliable go-to for precise and up-to-date information!
We are dedicated to accuracy, impartiality, and providing news as it unfolds, earning the trust of a wide audience. Keep up with real-time updates on the latest events and trends.